JPRN-UMIN000047817招募中未知
Acceleration of clinical tests, including molecular testing of infectious diseases and social implementation research of mobile laboratories and smart laboratories - Social implementation research of mobile laboratories and smart laboratories
niversity of Tsukuba Hospital0 个研究点目标入组 10,000 人开始时间: 2022年5月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 10,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •We excluded the following patients Patients who requested to withdraw after giving their consent for the clinical performance test. Regarding the secondary use of samples used in other studies, if there an individual requested the refusal of the sample for secondary use, the sample will be excluded from the target.
研究者
相似试验
招募中
不适用
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of Non-Small Cell Lung Carcinoma PatientsMetastatic Non-small Cell Lung Cancer (NSCLC)C34Malignant neoplasm of bronchus and lungDRKS00010126AIO-Studien-gGmbH5,000
已完成
不适用
Evaluating new point-of-care diagnostic tests for COVID-19COVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN86124626Manchester University NHS Foundation Trust1,000
已完成
不适用
Clinical verification of an improved assay of "NX-PVKA-R", which associated with des-gamma-carboxyprothrombin, for diagnosis of patients with hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000007196Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine25
招募中
不适用
The low platelet blood studyHaematological DisordersThrombocytopeniaISRCTN95606674niversity of Bristol100
招募中
1 期
An Imaging Phase I B Study Evaluating MK-0646 in Combination with Erlotinib for Patients with Advanced Non-Small Cell Lung CancerCTRI/2009/091/000139Merck & Co., Inc. One Merck DriveP.O. Box 100Whitehouse Station, NJ, 08889-0100, U.S.A.106